Results2 Nov 2026 · Fri 3:35 PM
GAILGAIL (India)
GAIL's Q2 consolidated profit rises 137% to ₹4,724 crore; board backs GAIL Gas IPO
GAIL reported September-quarter consolidated net profit of ₹4,723.75 crore against ₹1,988.71 crore a year earlier, and its board gave in-principle approval to list GAIL Gas through an IPO.
Price, Friday's close₹167.91▲ 1.66%
Last 5 days
52-week low ₹134.3652-week high ₹182.38
- Sector
- Gas utilities
What happened
- The Free Press Journal, in a report timed at 3:35 PM on Friday, gave consolidated net profit as ₹4,723.75 crore, up 137.5%, and revenue from operations as ₹47,301.03 crore against ₹35,657.23 crore, up 32.68%. Earnings per share were ₹7.18 against ₹3.00.
- The Tribune gave standalone profit after tax as ₹4,650 crore on revenue of ₹45,924 crore. It put first-half standalone profit at ₹8,943 crore against ₹4,104 crore.
- The Tribune said the board gave in-principle approval to list GAIL Gas by IPO. Valuation, price band and stake size are to be set by the lead managers and need a further board approval.
- The Free Press Journal noted a ₹3,831 crore contingent liability for an excise demand on naphtha classification, with an appeal pending before the Supreme Court.
Why it matters
This result was filed on Friday afternoon but was not in Friday evening's edition.
Good to know: A contingent liability is an obligation that depends on the outcome of a future event, here a court appeal. It is disclosed in the accounts but not counted as an expense unless the company is required to pay.
Key facts
- Consolidated net profit, per Free Press Journal
- ₹4,723.75 crore (₹1,988.71 crore), up 137.5%
- Revenue from operations, per Free Press Journal
- ₹47,301.03 crore, up 32.68%
- Standalone profit after tax, per The Tribune
- ₹4,650 crore
- Contingent liability (naphtha excise), per Free Press Journal
- ₹3,831 crore; appeal pending in the Supreme Court
Read the source
This is a summary of public news about GAIL (India), for information only. It is not a recommendation to buy, sell or hold GAIL.